Article Text

Download PDFPDF
Long-term progression-free survival of invasive uterine cervical carcinoma infected with human immunodeficiency virus: a case report
  1. Y. Niibe*,
  2. K. Karasawa* and
  3. K. Mizutani
  1. * Department of Radiology and Radiation Oncology, Tokyo Metropolitan Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo, Japan
  2. Department of Gynecology, Tokyo Metropolitan Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo, Japan
  1. Address for correspondence and reprint request to: Yuzuru Niibe, MD, PhD, Department of Radiology, Kitasato University School of Medicine, 1-15-1, Kitasato, Sagamihara 228-8555, Japan. Email: joe-n{at}


We report the case of a patient with invasive uterine cervical carcinoma, who is also infected with human immunodeficiency virus. This patient has had the longest progression-free survival of any with acquired immunodeficiency syndrome uterine cervical carcinoma. She was found to be human immunodeficiency virus positive in February 1996 and found to have uterine cervical carcinoma stage IB in July 1996. Shortly thereafter, she underwent radiation therapy. She died of renal and liver failure in January 1999. However, no residual tumor existed at that time. The longest progression-free survival in this case may be attributable to maintenance of the CD4 cell count from the onset of uterine cervical carcinoma to death, which meant the patient's immune system to the cancer cells worked.

  • AIDS
  • uterine cervical carcinoma
  • radiation therapy

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.